News & Updates

Cumulative immunomodulator exposure may heighten risk of CIN2+ in IBD
Cumulative immunomodulator exposure may heighten risk of CIN2+ in IBD
16 Jun 2023

Among women with inflammatory bowel disease (IBD), those who have long-term immunomodulator exposure are at increased risk of high-grade cervical intraepithelial neoplasia and cervical cancer (CIN2+), according to a study.

Cumulative immunomodulator exposure may heighten risk of CIN2+ in IBD
16 Jun 2023
Post-treatment HBsAg loss greater with TDF vs entecavir
Post-treatment HBsAg loss greater with TDF vs entecavir
12 Jun 2023

In patients with chronic hepatitis B (CHB) without cirrhosis, the rates of hepatitis B surface antigen (HBsAg) loss appear to be higher after discontinuation of tenofovir disoproxil fumarate (TDF) than of entecavir, and this is particularly true for patients who have not experienced relapse after treatment discontinuation, according to a study.

Post-treatment HBsAg loss greater with TDF vs entecavir
12 Jun 2023
Flavonoid intake improves survival after CRC diagnosis
Flavonoid intake improves survival after CRC diagnosis
11 Jun 2023

Patients who have been diagnosed with colorectal cancer (CRC) may benefit from increased flavonoid intake, which has been shown to reduce CRC-specific mortality in a recent study.

Flavonoid intake improves survival after CRC diagnosis
11 Jun 2023